These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 15317654)

  • 1. Disparities in lipid management for African Americans and Caucasians with coronary artery disease: a national cross-sectional study.
    Massing MW; Foley KA; Carter-Edwards L; Sueta CA; Alexander CM; Simpson RJ
    BMC Cardiovasc Disord; 2004 Aug; 4():15. PubMed ID: 15317654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial disparities in lipid control in patients with diabetes.
    Saffar D; Williams K; Lafata JE; Divine G; Pladevall M
    Am J Manag Care; 2012 Jun; 18(6):303-11. PubMed ID: 22774998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial differences in switching, augmentation, and titration of lipid-lowering agents by Medicare/Medicaid dual-eligible patients.
    Mark TL; Axelsen KJ; Mucha L; Sadkova Y
    Am J Manag Care; 2007 Jun; 13 Suppl 3():S72-9. PubMed ID: 17596115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study.
    García Ruiz FJ; Marín Ibáñez A; Pérez-Jiménez F; Pintó X; Nocea G; Ahumada C; Alemao E; Yin D;
    Pharmacoeconomics; 2004; 22 Suppl 3():1-12. PubMed ID: 15669149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pattern of dyslipidemia among urban African-Americans with type 2 diabetes.
    Cook CB; Erdman DM; Ryan GJ; Greenlund KJ; Giles WH; Gallina DL; El-Kebbi IM; Ziemer DC; Ernst KL; Dunbar VG; Phillips LS
    Diabetes Care; 2000 Mar; 23(3):319-24. PubMed ID: 10868858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary prevention in a cardiology group practice and hospital setting after a heart-care initiative.
    LaBresh KA; Owen P; Alteri C; Reilly S; Albright PS; Hordes AR; Shaftel PA; Noonan TE; Stoukides CA; Kaul AF
    Am J Cardiol; 2000 Feb; 85(3A):23A-29A. PubMed ID: 10695704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is lipid-lowering therapy underused by African Americans at high risk of coronary heart disease within the VA health care system?
    Woodard LD; Kressin NR; Petersen LA
    Am J Public Health; 2004 Dec; 94(12):2112-7. PubMed ID: 15569962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding disparities in lipid management among patients with type 2 diabetes: gender differences in medication nonadherence after treatment intensification.
    Billimek J; Malik S; Sorkin DH; Schmalbach P; Ngo-Metzger Q; Greenfield S; Kaplan SH
    Womens Health Issues; 2015; 25(1):6-12. PubMed ID: 25442365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial differences in reaching target low-density lipoprotein goal among individuals treated with prescription statin therapy.
    Yood MU; McCarthy BD; Kempf J; Kucera GP; Wells K; Oliveria S; Stang P
    Am Heart J; 2006 Oct; 152(4):777-84. PubMed ID: 16996858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are racial disparities in stroke care still prevalent in certified stroke centers?
    Bhattacharya P; Mada F; Salowich-Palm L; Hinton S; Millis S; Watson SR; Chaturvedi S; Rajamani K
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):383-8. PubMed ID: 22078781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, treatment, and control of hypertension among African Americans and Caucasians at primary care sites for medically under-served patients.
    Sheats N; Lin Y; Zhao W; Cheek DE; Lackland DT; Egan BM
    Ethn Dis; 2005; 15(1):25-32. PubMed ID: 15720046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals.
    Pearson TA; Laurora I; Chu H; Kafonek S
    Arch Intern Med; 2000 Feb; 160(4):459-67. PubMed ID: 10695686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry.
    Nanna MG; Navar AM; Zakroysky P; Xiang Q; Goldberg AC; Robinson J; Roger VL; Virani SS; Wilson PWF; Elassal J; Lee LV; Wang TY; Peterson ED
    JAMA Cardiol; 2018 Aug; 3(8):739-748. PubMed ID: 29898219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial and ethnic differences in health care access and health outcomes for adults with type 2 diabetes.
    Harris MI
    Diabetes Care; 2001 Mar; 24(3):454-9. PubMed ID: 11289467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [LDL-cholesterol in secondary prevention: goal-attainment in patients on lipid-lowering drugs in private practice and in hospitals in Austria (ZIEL)].
    Föger B; Patsch JR
    Wien Klin Wochenschr; 2011 Jan; 123(1-2):21-7. PubMed ID: 21165704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-Five Year Secular Trends in Lipids and Modifiable Risk Factors in a Population-Based Biracial Cohort: The Coronary Artery Risk Development in Young Adults (CARDIA) Study, 1985-2011.
    Schreiner PJ; Jacobs DR; Wong ND; Kiefe CI
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of appropriate lipid management in patients with ischaemic heart disease. Cracovian Program for Secondary Prevention of Ischaemic Heart Disease.
    Kawecka-Jaszcz K; Jankowski P; Pajak A
    Int J Cardiol; 2003 Sep; 91(1):15-23. PubMed ID: 12957725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study.
    O'Meara JG; Kardia SL; Armon JJ; Brown CA; Boerwinkle E; Turner ST
    Arch Intern Med; 2004 Jun; 164(12):1313-8. PubMed ID: 15226165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a targeted intervention on lipid-lowering therapy in patients with coronary artery disease in the hospital setting.
    Lacy CR; Suh DC; Barone JA; Bueno M; Moylan D; Swartz C; Kudipudi RV; Kostis JB
    Arch Intern Med; 2002 Feb; 162(4):468-73. PubMed ID: 11863482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors, barriers, and facilitators of lipid-lowering medication use among African Americans in a primary care clinic.
    Schwartz KL; Dailey R; Bartoces M; Binienda J; Archer C; Neale AV
    J Natl Med Assoc; 2009 Sep; 101(9):944-52. PubMed ID: 19806853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.